Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis (Q44484748)

3 December 2017

title

Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis (English)

1 reference

3 December 2017

0 references

N Eiró

1

1 reference

3 December 2017

C Ovies

2

1 reference

3 December 2017

B Fernandez-Garcia

3

1 reference

3 December 2017

C C Álvarez-Cuesta

4

1 reference

3 December 2017

L González

5

1 reference

3 December 2017

L O González

6

1 reference

3 December 2017

F J Vizoso

7

1 reference

3 December 2017

publication date

21 November 2012

1 reference

Archives of Dermatological Research

3 December 2017

published in

1 reference

3 December 2017

volume

305

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

59-67

1 reference

https://scigraph.springernature.com/pub.10.1007/s00403-012-1300-y

3 December 2017

exact match

0 references

cites work

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

TLR3 and TLR4 expression in healthy and diseased human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Tumor necrosis factor or tumor promoting factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Prediction of outcome for patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

The interplay between innate and adaptive immunity regulates cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Toll-like receptors and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Immunotherapy for advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

TLR signaling by tumor and immune cells: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Activation of Toll-like Receptors 1, 2, 4, 5, and 7 on Human Melanocytes Modulate Pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Imiquimod, a Toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Immune response profiles in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Role of chemokines in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

The melanoma epidemic: more apparent than real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1300-Y

10.1007/S00403-012-1300-Y

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference